← Every applicant

Biofire Diagnostics, LLC FDA Approvals

0 new drug approvals and 12 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini510(k)Aug 14, 2025Microbiology
BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid510(k)Jan 16, 2025Microbiology
BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack) RFIT-ASY-0148 (6 pack))510(k)Dec 20, 2024Microbiology
BIOFIRE FILMARRAY Gastrointestinal (GI) Panel510(k)Nov 7, 2024Microbiology
BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini510(k)May 30, 2024Microbiology
BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel510(k)Mar 26, 2024Microbiology
BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini510(k)Apr 13, 2023Microbiology
BIOFIRE FILMARRAY Gastrointestinal (GI) Panel510(k)Mar 16, 2023Microbiology
FilmArray Pneumonia Panel plus510(k)Oct 27, 2022Pathology
BioFire Joint Infection (JI) Panel510(k)Apr 29, 2022Microbiology
FilmArray Pneumonia Panel510(k)Sep 22, 2021Microbiology
BioFire Respiratory Panel 2.1 (RP2.1)510(k)Mar 17, 2021Microbiology

Related datasets